|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007226,
umls-concept:C0015737,
umls-concept:C0027051,
umls-concept:C0030705,
umls-concept:C0034975,
umls-concept:C0087111,
umls-concept:C0162791,
umls-concept:C0205178,
umls-concept:C1257890,
umls-concept:C1274040,
umls-concept:C1511726,
umls-concept:C1522318,
umls-concept:C1948041
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-11-24
|
|
pubmed:abstractText |
Despite the 2000 and 2007 redefinition of myocardial infarction (MI), patients who are troponin (Tn) positive ([+]) but MB negative ([-]) may not be considered to have MI, particularly in the absence of known coronary disease (prior MI or revascularization; coronary artery disease [CAD]). How this affects treatment and outcomes has not been well described.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1097-6744
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 Mosby, Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
160
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
819-25
|
|
pubmed:meshHeading |
pubmed-meshheading:21095267-Aged,
pubmed-meshheading:21095267-Aged, 80 and over,
pubmed-meshheading:21095267-Antithrombins,
pubmed-meshheading:21095267-Biological Markers,
pubmed-meshheading:21095267-Coronary Angiography,
pubmed-meshheading:21095267-Creatine Kinase, MB Form,
pubmed-meshheading:21095267-Drug Therapy, Combination,
pubmed-meshheading:21095267-Electrocardiography,
pubmed-meshheading:21095267-Female,
pubmed-meshheading:21095267-Follow-Up Studies,
pubmed-meshheading:21095267-Hospital Mortality,
pubmed-meshheading:21095267-Humans,
pubmed-meshheading:21095267-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:21095267-Male,
pubmed-meshheading:21095267-Middle Aged,
pubmed-meshheading:21095267-Myocardial Infarction,
pubmed-meshheading:21095267-Myocardial Revascularization,
pubmed-meshheading:21095267-Platelet Aggregation Inhibitors,
pubmed-meshheading:21095267-Practice Guidelines as Topic,
pubmed-meshheading:21095267-Prognosis,
pubmed-meshheading:21095267-Registries,
pubmed-meshheading:21095267-Retrospective Studies,
pubmed-meshheading:21095267-Risk Factors,
pubmed-meshheading:21095267-Ticlopidine,
pubmed-meshheading:21095267-Troponin,
pubmed-meshheading:21095267-United States
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Troponin-positive, MB-negative patients with non-ST-elevation myocardial infarction: An undertreated but high-risk patient group: Results from the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network-Get With The Guidelines (NCDR ACTION-GWTG) Registry.
|
|
pubmed:affiliation |
Division of Cardiology, Department of Internal Medicine, Pauley Heart Center, Virginia Commonwealth University, Richmond, VA, USA. mkontos@mcvh-vcu.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial
|
